Podcasts

Join Professors Ed Vital, Cynthia Aranow, and Richard Furie as they discuss the key takeaways from their recent webinar focusing on the following topics: new and emerging pathways in the treatment of SLE, advances in treatment of SLE, and The challenges confronting SLE clinical trials.

Our Steering Committee experts Professor Victoria Werth and Chris Edwards join the latest Lupus Forum podcast to discuss the effect of belimumab vs placebo on mucocutaneous manifestations of SLE, and the long-term impact of anifrolumab vs placebo on LLDAS and DORIS attainment in patients with SLE.

Professor Richard Furie (Northwell Health, New York) and Professor Victoria Werth (University of Pennsylvania) join the latest Lupus Forum podcast to discuss efficacy and safety of belimumab or telitacicept as sequential treatment after rituximab in LN and the efficacy and safety of obinutuzumab in LN.

Join Professors Ed Vital and Brad Rovin as they summarise the "Challenges in LN" webinar, covering the importance of early diagnosis, implications of delayed diagnosis, and barriers to early diagnosis associated with lupus nephritis.

Professor Vibeke Stand (Stanford University) and Professor Eric Morand (Monash University) join the latest Lupus Forum podcast to discuss LLDAS and remission in SLE patients with HDAS, as well as the latest APLAR treatment consensus for LN.

Steering Committee member Professor Maria Dall’Era, Professor of Medicine and Chief of the Division of Rheumatology at the of University of California, San Francisco, USA, is joined by fellow member Professor Brad Rovin, who is Lee A. Hebert Professor of Nephrology and Medical Director at Ohio State University Clinical Research Management Institute, Columbus, Ohio, on the latest Lupus Forum podcast.

Together, they discuss the efficacy and safety of a voclosporin-based triple immunosuppressive regimen and summarise the latest ACR guidance to screen, treat, and manage lupus nephritis.